secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2026-08-19T12:30:25+00:00
Accession:  0001493152-26-039135
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma distributes investor presentation; content not disclosed in 8-K
--------------------------------------------------------------------------------

- Company intends to distribute an investor presentation dated August 19, 2026.
- Presentation furnished as Exhibit 99.1; no financial figures in the 8-K body.
- No specific operational or financial updates provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226039135/0001493152-26-039135-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226039135/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-039135

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer